SPYRE
LIVE

Serial Number

79388359

Owner

Lunaphore Technologies SA

Attorney

Courtney Thompson

Filing Date

Sep 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

SPYRE Trademark

Serial Number: 79388359 • Registration: 7699834

SPYRE is a trademark filed by Lunaphore Technologies SA on September 1, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Lunaphore Technologies SA (7 trademarks)

Route de Lully 5C

Entity Type: 33

Trademark Details

Filing Date

September 1, 2023

Registration Date

February 25, 2025

Published for Opposition

January 7, 2025

Goods & Services

Biochemical preparations and biotechnological products in the nature of antibody panels for industrial and scientific use; diagnostic preparations for scientific use; diagnostic reagents for science or research; biochemicals, in particular antibodies for in vitro scientific use; kits for industrial and scientific use containing biochemical preparations and biotechnological products in the nature of antibody panels for the preparation of samples, the separation, isolation, purification, amplification and/or analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits comprising antibodies for in vitro scientific use for the preparation of samples, the separation, isolation, purification, amplification and/or analysis of biopolymers all for industrial and scientific use

Medical and veterinary preparations for the treatment of cancer, tumors, immune system conditions, and metabolic diseases; diagnostic substances, preparations and agents for medical use; diagnostic preparations for medical use; diagnostic reagents for medical or veterinary use; diagnostic biomarking reagents for medical use; diagnostic substances for medical use; antibodies for medical use; biological reagents for medical use; diagnostic kits consisting of medical diagnostic reagents for use in detecting nucleic acids, proteins, macromolecules and biologically active substances for medical use; in vitro diagnostic kit containing antibodies for medical use.

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 3, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 13, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 18, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 1, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 1, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 25, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 25, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 7, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 11, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 11, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 11, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 11, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 10, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 3, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 18, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 18, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2024 TROA
REFUSAL PROCESSED BY IB
May 22, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 1, 2024 RFCS
REFUSAL PROCESSED BY MPU
May 1, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 22, 2024 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2024 NREP
APPLICATION FILING RECEIPT MAILED
Feb 6, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 2, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 1, 2024 REPR